Danish Medical Agency approves CTA application for AP-1189 in nephrotic syndrome June 3, 2020 No Comments
FDA approves VESIcare LS oral suspension for neurogenic detrusor overactivity in pediatric patients May 28, 2020 No Comments
CCX-140 shows no meaningful reduction in proteinuria in phase II study in FSGS May 18, 2020 No Comments